Collectively, our findings showed that DCN overexpression inhibited the fibrosis and inflammation in DCM through reduction of TGF-β1 and inactivation of NF-κB respectively, which may be mediated by IGF-IR/PKCα/hsp70 pathway. The gene discussed is NFKB1; the disease is familial dilated cardiomyopathy.